ProfileGDS5678 / 1453370_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 19% 20% 19% 18% 21% 21% 18% 19% 19% 20% 19% 20% 19% 19% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4831419
GSM967853U87-EV human glioblastoma xenograft - Control 22.4677620
GSM967854U87-EV human glioblastoma xenograft - Control 32.4661619
GSM967855U87-EV human glioblastoma xenograft - Control 42.3927118
GSM967856U87-EV human glioblastoma xenograft - Control 52.4417521
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5573621
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4644218
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4359719
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4409119
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4650120
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4500919
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4484520
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4643419
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4572219